Gossamer Bio Analyst Ratings
BenzingaApr 5 16:55
Gossamer Bio Analyst Ratings
BenzingaMar 28 00:41
Buy Rating Affirmed on Gossamer Bio With Promising Seralutinib Prospects in PAH Treatment Landscape
TipRanksMar 27 21:55
Gossamer Bio (GOSS) Receives a Buy From Piper Sandler
TipRanksMar 27 19:06
Analysts Offer Insights on Healthcare Companies: Diamedica Therapeutics (DMAC), Gossamer Bio (GOSS) and Vor Biopharma (VOR)
TipRanksMar 21 21:00
Piper Sandler Sticks to Its Buy Rating for Gossamer Bio (GOSS)
TipRanksMar 13 18:55
Barclays Keeps Their Hold Rating on Gossamer Bio (GOSS)
TipRanksMar 11 14:45
Gossamer Bio Analyst Ratings
BenzingaMar 6 21:42
HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target
BenzingaMar 6 21:44
Strong Buy Rating on Gossamer Bio Amidst Seralutinib's Promising Trials and Solid Financials
TipRanksMar 6 20:55
Gossamer Bio Earns 'Buy' Rating From Analyst Citing Progress in Seralutinib Trials and Strategic Market Expansion
TipRanksMar 6 09:15
Maintained Buy Rating on Gossamer Bio Amidst Anticipated Phase 3 PROSERA Trial Results
TipRanksMar 6 07:15
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Neurogene (NGNE) and Gossamer Bio (GOSS)
TipRanksJan 8 19:30
HC Wainwright & Co. Maintains Buy on Gossamer Bio, Raises Price Target to $10
BenzingaJan 8 19:27
Gossamer Bio Analyst Ratings
BenzingaJan 8 19:26
Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Gossamer Bio (GOSS) and 4D Molecular Therapeutics (FDMT)
TipRanksJan 4 20:21
Wedbush Reiterates Outperform on Gossamer Bio, Maintains $6 Price Target
BenzingaDec 19, 2023 21:39
Gossamer Bio Analyst Ratings
BenzingaDec 19, 2023 21:38
Analysts Are Bullish on These Healthcare Stocks: Gossamer Bio (GOSS), Viridian Therapeutics (VRDN)
TipRanksDec 19, 2023 19:50
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Viracta Therapeutics (VIRX) and Gossamer Bio (GOSS)
TipRanksNov 14, 2023 16:30
No Data
No Data